(Q36836556)

16 August 2017

1 reference

title

Right ventricular failure in patients with preserved ejection fraction and diastolic dysfunction: an underrecognized clinical entity (English)

1 reference

16 August 2017

1 reference

1 reference

Ramzan M Zakir

1

1 reference

16 August 2017

Anthony Al-Dehneh

2

1 reference

16 August 2017

James Maher

3

1 reference

16 August 2017

Muhamed Saric

4

1 reference

16 August 2017

Robert L Berkowitz

5

1 reference

16 August 2017

1 May 2007

1 reference

16 August 2017

Congestive Heart Failure

1 reference

16 August 2017

13

1 reference

16 August 2017

164-169

1 reference

16 August 2017

3

1 reference

Epidemiology of diastolic heart failure

16 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06408.X

Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06408.X

Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06408.X

Evaluation and management of diastolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06408.X

Determinants of pulmonary hypertension in left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06408.X

Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06408.X

Results from late-breaking clinical trial sessions at the American College of Cardiology 51st Annual Scientific Session

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06408.X

Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06408.X

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06408.X

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06408.X

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06408.X

Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06408.X

Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06408.X

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06408.X

Nesiritide for the treatment of diastolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06408.X

Reversibility of Medically Unresponsive Pulmonary Hypertension with Nesiritide in a Cardiac Transplant Recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06408.X

10.1111/J.1527-5299.2007.06408.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference